Tony Jackson

Pfizer Inc.'s stock traded modestly higher near $27.14 in late February 2026, closing at $27.14 on February 24 after a 0.30% gain, as the pharmaceutical giant builds on solid fourth-quarter and full-year 2025 results that beat expectations while reaffirming its 2026 outlook despite anticipated revenue pressures from declining COVID-19 products and patent expirations.

Feb 26, 2026

CleanSpark Inc.'s stock rallied 5.4% to close at $10.35 on February 24, 2026, rebounding from recent pressure as investors focused on the company's strategic shift toward high-performance computing (HPC) and AI infrastructure, even after reporting a wider-than-expected net loss in fiscal first-quarter 2026 results released earlier in February.

Feb 26, 2026

GameStop Corp.'s stock has stabilized near $24 in late February 2026, closing at $23.92 on February 25 after a modest 0.63% gain, as renewed retail investor enthusiasm and CEO Ryan Cohen's comments on pursuing transformative acquisitions keep the meme stock in focus despite ongoing challenges in the core retail business.

Feb 26, 2026

UiPath Inc.'s stock has shown resilience in late February 2026, closing at $10.10 on February 24 after a 0.69% decline

Feb 25, 2026

IREN Limited shares rallied sharply on February 24, 2026, closing at $45.45 after jumping 7.29%, extending a volatile but upward trend as the former Bitcoin miner-turned-AI cloud infrastructure provider benefits from major hyperscaler deals and institutional interest, even after a recent earnings miss highlighted execution challenges in its pivot.

Feb 25, 2026

Micron Technology Inc.'s stock has surged in early 2026, trading near $420 after a strong year-to-date rally fueled by explosive demand for high-bandwidth memory (HBM) in artificial intelligence data centers, record fiscal first-quarter results, and full commitment of its 2026 HBM production under multi-year contracts.

Feb 25, 2026

Bank of America Corp.'s stock has retreated in late February 2026, closing at $50.41 on February 24 after a 1.29% decline

Feb 25, 2026

ImmunityBio Inc.'s stock has skyrocketed in early 2026, surging more than 500% year-to-date and hitting new 52-week highs above $11 as explosive sales growth for its flagship immunotherapy ANKTIVA, coupled with rapid international regulatory approvals and partnerships, fuels investor enthusiasm for the cancer-focused biotech.

Feb 25, 2026

U.S. stock markets have navigated a turbulent February 2026, with major indices swinging between gains and losses amid persistent investor concerns over artificial intelligence's disruptive potential, elevated capital spending by tech giants, and renewed tariff threats under the current administration.

Feb 25, 2026

The Nasdaq Composite Index has endured choppy trading in February 2026, retreating from recent highs near 23,000 to hover around 22,800 as investors weigh heavy artificial intelligence infrastructure spending against potential economic headwinds, including renewed tariff threats and policy shifts.

Feb 25, 2026

Netflix's weekly Top 10 movie rankings continue to be the most reliable pulse of what the world is actually watching in 2026.

Feb 05, 2026